![](/img/cover-not-exists.png)
Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status
Hata, Nobuhiro, Yoshimoto, Koji, Hatae, Ryusuke, Kuga, Daisuke, Akagi, Yojiro, Sangatsuda, Yuhei, Suzuki, Satoshi O, Shono, Tadahisa, Mizoguchi, Masahiro, Iihara, KojiVolume:
Volume 10
Language:
english
Journal:
OncoTargets and Therapy
DOI:
10.2147/OTT.S125587
Date:
January, 2017
File:
PDF, 825 KB
english, 2017